{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:12:46Z","timestamp":1793419966005,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/wnf.0b013e31829ae713","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T07:21:50Z","timestamp":1373959310000},"page":"103-106","source":"Crossref","is-referenced-by-count":203,"title":["N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases"],"prefix":"10.1097","volume":"36","author":[{"given":"Mary J.","family":"Holmay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Terpstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ahlskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclin","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Tuite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinsons disease and other neurodegenerative disorders affecting basal ganglia.","volume":"36","author":"Sian","year":"1994","journal-title":"Ann Neurol"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.21023","article-title":"Altered Intracellular Redox Status in Gaucher Disease Fibroblasts and Impairment of Adaptive Response Against Oxidative Stress.","volume":"21","author":"DeGanuto","year":"2007","journal-title":"J Cell Physiol"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cca.2005.07.022","article-title":"Blood oxidative stress markers in Gaucher disease patients.","volume":"364","author":"Roversi","year":"2006","journal-title":"Clinica Chimica Acta"},{"issue":"9","key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0891-5849(02)00780-3","article-title":"Oxidatively modified proteins in aging and disease.","volume":"32","author":"Beal","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-4159.2008.05604.x","article-title":"Mitochondrial alterations in Parkinsons disease: new clues.","volume":"107","author":"Vila","year":"2008","journal-title":"J Neurochem"},{"issue":"100","key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1212\/WNL.66.10_suppl_4.S37","article-title":"Proteasomal dysfunction in sporadic Parkinsons disease.","volume":"66","author":"McNaught","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 3","key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinsons disease.","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinsons disease.","volume":"361","author":"Sidranski","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocereborsidase mutations and parkinsonism.","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol Med"},{"issue":"7","key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22401","article-title":"Randomized. double-blind, pilot evaluation of intravenous glutathione in Parkinsons disease.","volume":"24","author":"Hauser","year":"2009","journal-title":"Movement Disorders"},{"issue":"6","key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","article-title":"Metabolism and functions of glutathione in brain.","volume":"62","author":"Dringen","year":"2000","journal-title":"Prog Neurobiol"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1254\/jphs.08R01CR","article-title":"Regulation of glutathione synthesis.","volume":"108","author":"Aoyama","year":"2008","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.","volume":"9","author":"Aoyama","year":"2006","journal-title":"Nat Neurosci"},{"issue":"3","key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1179\/135100009X392539","article-title":"Role of N-acetylcysteine in glutathione synthesis in human erythrocytes.","volume":"14","author":"Whillier","year":"2009","journal-title":"Redox Report"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ana.22162","article-title":"N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-1- mouse.","volume":"69","author":"Berman","year":"2011","journal-title":"Ann Neurol"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimers disease.","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/mrm.22086","article-title":"In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T.","volume":"62","author":"Tkac","year":"2009","journal-title":"Magn Reson Med"},{"issue":"2","key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1","article-title":"Field mapping without reference scan using asymmetric echo-planar techniques.","volume":"43","author":"Gruetter","year":"2000","journal-title":"Magn Reson Med"},{"issue":"4","key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/mrm.22708","article-title":"Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: validation in the cerebellum and brainstem.","volume":"65","author":"Oz","year":"2011","journal-title":"Magn Reson Med"},{"issue":"4","key":"R21-1-20210203","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel.","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed"},{"issue":"3","key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites.","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed"},{"issue":"3","key":"R24-1-20210203","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mrm.1910320304","article-title":"Analysis of macromolecule resonances in 1H NMR spectra of human brain.","volume":"32","author":"Behar","year":"1994","journal-title":"Magn Reson Med"},{"issue":"3","key":"R26-1-20210203","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/01.STR.22.3.324","article-title":"Quantitative assessment of cerebral blood volume by single-photon emission computed tomography.","volume":"22","author":"Sabatini","year":"1991","journal-title":"Stroke"},{"issue":"1","key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0030918","article-title":"Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 Tesla proton MRS.","volume":"7","author":"Emir","year":"2012","journal-title":"Plos One"},{"issue":"2","key":"R28-1-20210203","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mrm.20761","article-title":"Proton MRS of the unilateral substantia nigra in the human brain at 4 Tesla: detection of high GABA concentrations.","volume":"55","author":"Oz","year":"2006","journal-title":"Magn Reson Med"},{"issue":"7","key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.","volume":"66","author":"Grant","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"R30-1-20210203","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/WNL.47.5.1264","article-title":"Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine.","volume":"47","author":"Hurd","year":"1996","journal-title":"Neurology"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e31829ae713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:15:29Z","timestamp":1620962129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201307000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31829ae713","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}